<DOC>
	<DOCNO>NCT00154778</DOCNO>
	<brief_summary>The purpose study evaluate response rate Paclitaxel combination chemotherapy UFT Leucovorin patient advance gastric cancer .</brief_summary>
	<brief_title>Taxol ( Paclitaxel ) , UFT Leucovorin Patients With Advanced Gastric Cancer</brief_title>
	<detailed_description>Since 1982 , cancer lead cause death Taiwan . In particular , gastric cancer fourth lead cause death male cancer patient sixth female patient 2000 , account estimate 2,374 death . In recent year , treatment gastric cancer patient gradually improve due advance early diagnosis surgical technique . Although chemotherapy radiation therapy use either adjuvant palliative setting , value still limit due unacceptable toxicity inadequate efficiency .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>1 . At least 18 year old 2 . Patients histologically confirm gastric adenocarcinoma , define locally advanced unresectable metastatic recurrent disease 3 . Patients least one measurable lesion 4 . ECOG performance status 0,1 2 5 . Patients prior chemotherapy radiotherapy metastatic disease ( patient receive complete prior adjuvant chemotherapy least 6 month prior study enrollment may enrol study , prior taxane chemotherapy exclude ) 6 . Patients physiological function ( bone marrow , heart , liver , kidney , etc . ) meeting follow criterion : WBC &gt; 4000/mm3 , ANC &gt; 1500/mm3 , PLT &gt; 100,000/mm3 , Hb &gt; 9.0g/dL , ALT &lt; 3 time ULN ( &lt; 5 time ULN liver metastasis case ) , Total bilirubin &lt; 1.5mg/dL , Creatinine &lt; upper limit normal 7 . Accessible treatment followup 8 . Give write informed consent 9 . Women child bear potential must negative plasma urine pregnancy test within 72 hour prior start study medication 1 . Patients receive surgery within 14 day prior enrollment 2 . Patients CNS metastasis 3 . History hypersensitivity relate administration polyoxyethylatedcastoroil ( cremophor EL ) contain preparation ( e.g . cyclosporin , etc . ) hardenedcastoroilcontaining preparation ( e.g . vitamin preparation injection , etc . ) 4 . Patients history severe hypersensitivity 5 . Active infectious symptom 6 . Patients active gastrointestinal bleeding , intestinal obstruction situation dose allow oral intake medication 7 . Patients ascites adversely affect performance status 8 . Preexisting CTC Grade 2 great neuropathy ( motor sensory ) 9 . Pregnant nursing female 10 . Patients participate clinical trial within 30 day prior first dose study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>Combination , Chemotherapy , Advanced Gastric Cancer</keyword>
</DOC>